Scope of Development Project. The Parties shall, during the Development Period, use reasonable efforts to work cooperatively with each other in order to perform the Development Project described in the Statement of Work in Appendix B1 pursuant to the schedule contained therein. This initial Statement of Work in Appendix B1 relates to development of a detailed and comprehensive plan that would help shape the technical direction of one or more subsequent SOWs to develop the Licensed Product. Subsequent SOWs may cover one or more of the following: Research and development, consisting of design, modeling, and testing of a MEMS-based magnetometer concept. Research and Development of the associated electronics, choice of magnetic and semiconductor materials. Research and Development of the fabrication methods including packaging of a MEMS-based magnetometer. Formulation of an initial manufacturing plan for a MEMS-based magnetometer. _______________________ * Any term in capital letters which is defined in Appendix A - Definitions shall have the meaning specified therein.
Scope of Development Project. (a) As part of the Development Project, the Parties shall jointly develop semiconductor manufacturing process technology based on an industry standard technology roadmap that meets the requirements set forth as “Strategic Technology Objectives” in Exhibit A in accordance with the schedule set forth on Exhibit B (the “Development Schedule”). The Parties shall create the Documentation identified on Exhibit C for the Development Project. For the avoidance of doubt, the Development Project shall not include the development of the following “Specific Results Exclusions”: i) Proprietary Tools, ii) Packaging Technology, iii) Mask Fabrication and Photoresist Technology, iv) Memory, v) SiGe Technology, vi) SOI Information, and vii)
Scope of Development Project. Lucent shall, during the Development Period, use reasonable efforts to perform the Development Project described in the Statement of Work in Appendix B pursuant to the schedule contained therein, and to provide the Deliverables to Company. The Deliverables may include Technical Information, Hardware and/or Software. Representatives for Lucent and Company shall meet as needed, either in person or by telephone, to evaluate and discuss the progress of the Development Project. The parties may, from time to time, agree upon additional statements of work that will likewise be appended to and become a part of this Agreement.
Scope of Development Project. The Parties shall, during the Development Period, use reasonable efforts to work cooperatively with each other in order to perform the Development Project described in the Statement of Work in Appendix B1 pursuant to the schedule contained therein. This initial Statement of Work in Appendix B1 relates to development of a detailed and comprehensive plan that would help shape the technical direction of one or more subsequent SOWs to develop the Licensed Product. Subsequent SOWs may cover one or more of the following: • Research and development relating to micro-power cell arrays employing nanotextured, superhydrophobic materials; • Research and development pertaining to electrolyte chemistry of the battery to produce tunable power level power cells of various voltages and durations; • Research and development pertaining to semiconductor technology interconnections needed to activate tunable arrays of micro power cells; • Development of any of the associated critical packaging technologies to commercially develop the Licensed Product; and • A working prototype of the Licensed Product that can be demonstrated (on a timeframe to be mutually agreed on) to external customers. During the course of the Development Project, it is anticipated that Developed Information will be produced by the Parties. Developed Information may include Technical Information, Hardware and/or Software. Representatives for Lucent and Company shall meet as needed, either in person or by telephone, to evaluate and discuss the progress of the Development Project. The parties may, from time to time, agree upon additional statements of work that will likewise be appended to and become a part of this Agreement. * Any term in capital letters which is defined in Appendix A – Definitions shall have the meaning specified therein. Back to Contents
Scope of Development Project. (a) As part of the Development Project, the Parties shall jointly develop semiconductor manufacturing process technology based on an industry standard technology roadmap that meets the requirements set forth as “Strategic Technology Objectives” in Exhibit A in accordance with the schedule set forth on Exhibit B (the “Development Schedule”). The Parties shall create the Documentation identified on Exhibit C for the Development Project. For the avoidance of doubt, the Development Project shall not include the development of the following “Specific Results Exclusions”: XXXXX The Parties are not obligated to exchange any updates to the Specific Results after the Project Term. IBM CONFIDENTIAL 5 Joint Development Project Agreement REDACTED Confidential Treatment Requested The portions of this document marked by “XXXXX” have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission Executable Version XXXXX Bulk-Industry Standard Semiconductor Process Technology
Scope of Development Project. (a) As part of the Development Project, the Parties shall jointly develop semiconductor manufacturing process technology based on an industry standard technology roadmap that meets the requirements set forth as “Strategic Technology Objectives” in Exhibit A in accordance with the schedule set forth on Exhibit B (the “Development Schedule”). The Parties shall create the Documentation identified on Exhibit C for the Development Project. For the avoidance of doubt, the Development Project shall not include the IBM CONFIDENTIAL 5 Joint Development Project Agreement Confidential Treatment Requested The portions of this document marked by “XXXXX” have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission
